INTRODUCTION
The morbidity and mortality from lung cancer account for 13 % and 19.4 % respectively, worldwide [1] . Lung cancer is classified into small cell lung carcinoma (SCLC) and non-small cell lung carcinoma (NSCLC). The latter (NSCLC) accounts for most (about 80 %) lung tumors. At present, early-stage NSCLC is treated by surgical intervention, while mid-late NSCLC is treated with radiotherapy and chemotherapy. Although effective for some patients in the short run, radiotherapy and chemotherapy are associated with adverse effects, toxicity, high recurrence of tumor and poor prognosis [2] . Therefore, it is necessary to reduce the side effects of chemotherapy drugs by searching for more effective anticancer drugs with lower toxicity. This has been a major challenge to medical science.
Camellia nitidissima C. W.
Chi is a very valuable plant in Guangxi of China. Studies have shown that Camellia nitidissima C. W. Chi has antiaging, blood pressure-lowering, hypoglycemic and immunity-enhancing properties [3] . It also has antioxidant activity [4] , and exerts cytotoxic effects on various malignant tumors [5, 6] . This study was carried out to investigate the effect of Camellia nitidissima C. W. Chi extract on proliferation and apoptosis in A549 human lung cancer cells.
EXPERIMENTAL Materials
Human lung cancer cell line (A549) was purchased from the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences. Camellia nitidissima C. W. Chi was obtained from Guangxi, China. RPMI1640 culture medium was a product of GIBCO Company, USA). Calf serum and phosphate buffer solution (PBS, American hyclone); dimethylthiozol-2-yl-2,5-diphenyl tetrazolium bromide (MTT), dimethyl sulfoxide (DMSO), propidium iodide (PI) and trypsin were obtained from Sigma-Aldrich (America). Caspase-3, caspase-8, caspase-9, Ki-67, bcl-2 p21 ras monoclonal antibodies, and SP generic kits were purchased from American NeoMarkers (San Francisco, USA) . 
Samples of

Preparation of CNCE
Dry leaves of Camellia nitidissima C. W. Chi (50 g) were ground and extracted three times by refluxing with 95 % ethanol, each time for 2 h. The extracts were pooled and concentrated under reduced pressure to obtain CNCE.
Cell culture
The A549 cells were cultured in RPMI-1640 medium (Gibco, Rockville, MD) containing 10 % fetal bovine serum (v/v) (FBS; Hyclone, Logan, UT) and 1% Penicillin Streptomycin (100 U/mL and 100 µg/mL, respectively) at 37 °C in a humidified atmosphere containing 5 % CO 2 , with 0.25 % trypsin digestion batches. The logarithmic phase of the cells were used for the study.
Drug sensitivity test
Cells at the logarithmic growth phase (in RPMI1640 medium) at a concentration of 1.0 × 10 5 cells/mL of cell suspension, were seeded in 48-well plates and cultured at 37 o C for 24 h, until the cells became adherent. CNCE at different final concentrations (30, 60, 120, 240 μg/mL) were added to different wells, and the wells were for different periods (24, 48 and 72 h) at 37 o C. A well containing 20 μg/mL cisplatin served as positive control, while another well containing saline in place of CNCE served as negative control.
Cell morphology assay
A suspension of A549 cells at the logarithmic growth phase in RPMI 164 medium was adjusted to a concentration of 1.0×10 5 cells/mL in a 48-well culture plate, and cultured for 24 h at 37 o C to achieve adherence. The wells were grouped into two. One group (experimental group) received different concentrations of CNCE (62.5, 125 or 250 ug/mL) in the culture medium, while the other group (control group) received 0.04 % DMSO in place of CNCE. The cells were observed under inverted microscope after 24, 48 and 72 h for changes in cell size, cell membrane and nucleus.
Growth curve and doubling time (TD) of A549 lung cancer cells
The A549 cells at logarithmic growth phase at a concentration of 1 × 10 4 cells/mL were seeded in 24-well plates. One milliliter was taken from each of three wells at the same time point daily, and digested. The number of cells per well was counted using a hemocytometer, and the mean number of cells was determined. Counting was done for 8 days. A growth curve was plotted with mean cell count as vertical axis, and time as horizontal axis. Doubling time (TD) for the human lung cancer A549 cells was calculated using Eq 1.
TD = t{log2/(logN t -logN o )} ………………. (1)
where t is time interval, while N o , and N t are the initial mean count and mean count after time t, respectively.
MTT assay
A suspension of the A549 cells (0.2 mL) at logarithmic phase was seeded in a 96-well plate with each well containing 5×10 3 cells, and cultured overnight for cell adhesion. In the experimental group, the original culture medium was drained, and replaced with different concentrations of freshly-prepared CNCE (one concentration in 24 wells, and 6 wells per group). The wells of the control group medium contained 0.04 % DMSO, while wells without cells served as blank control.
All wells were incubated for 24, 48, 72 and 96 h at 37 o C in a humid atmosphere containing 5 % CO 2. The supernatant was discarded, and 20 μL of MTT solution (5 g/L) was added to each well and incubated at 37 o C for 4 h. Then, the supernatant was carefully removed by suction, and 150 μL DMSO was added to each well to dissolve the crystals. The absorbance of each solution was read at 490 nm against blank control, and the results were used for calculating the growth inhibition rate.
FCM assay
A suspension of 549 human lung cancer cells (5.0 × 10 4 cells/mL) at logarithmic growth phase was seeded in 24-well plates (100 μL in each well), and cultured in RPMI 1640 medium for 24 h for adherence. Thereafter, CNCE was added to a final concentration of 40 μg/mL. Wells in the control group contained an equivalent volume of normal saline. The plates were cultured at 37 o C in an atmosphere of 5 % CO 2. At 24 and 48 h, the cells in each group were collected (cell number > 1 × 10 6 ), washed twice in cold PBS (pH 7. 2 -7. 4), and centrifuged at 1000 rpm for 5 min. Then, 1 mL of cold precipitation PBS (pH 7.2 -7.4) was added to the cell suspension, followed by 3 mL of pre-cooled 70 % ethanol.
The cell suspension was kept overnight at 4 o C, and then centrifugal at 1000 rpm for 5 min. The supernatant was discarded; and the cells were washed twice in 1 mL of cold PBS (pH 7.2 -7.4), and centrifuged at 1000 rpm for 5 min. The cell count was adjusted to 1 × 10 6 / mL, and 200 uL NaseA was added, followed by incubation in a 37 o C water bath for 30 min. Iodide C ingot (PI) staining fluid 800 µL was added, mixed and kept at 4 o C in the dark for 30 min. DNA single parameter analysis was carried out to determine cell distribution and the proportion of cells in G0/D1, S, and G2/M phases, as a function of time. The results were analyzed using Modifit LT software.
Immunocytochemistry staining
The A549 cells at logarithmic phase were digested with 0.25 % trypsin, and 2 × 10 5 cells were seeded into a 6-well plate and cultured overnight for cell adhesion. The culture medium was removed, and 3mL of CNCE was added to different cells to final concentrations of 30, 60, 120 and 240 μg/mL. Each CNCE concentration was replicated in six parallel wells. In the control wells, CNCE was replaced with an equivalent volume of 0.04 % DMSO. The plates were incubated for 24 and 48 h; the glass slides were taken out, dried and fixed with 4 % paraformaldehyde for 10 min at 
Statistical analysis
All data are expressed as mean ± standard error of mean (SEM), and processed using SPSS 16.0 (SPSS Inc., Illinois, Chicago, USA). They were analyzed by one-way analysis of variance (ANOVA) followed by Dunnett's t-test. P < 0.05 was considered statistically significant.
RESULTS
Effect of CNCE on proliferation of A549 cells
CNCE at different doses significantly inhibited the proliferation of A549 cells after 48 h when compared with control group (p < 0. 05). The inhibitory effect was dose-dependent. These results are shown in Table 1 . 
Effect of CNCE on cell morphology
Under the inverted microscope, the control group of lung cancer A549 cells grew densely, with overlapping clusters, as a long fusiform or polygon, without direction and with clear cellular edges. On the other hand, A549 cells treated with CNCE at concentrations of 10 and 20 ug/mL showed reduction in number of cells, and no obvious morphological changes. When the concentration of CNCE reached 40 ug/mL, the cell volume shrank, becoming smaller; and the cells were fewer and separated, with many of floating particles in the culture medium. At concentrations of 160 and 320 ug/mL of CNCE, there were very clear and obvious changes in cell morphology, and evidence of cell disruption and higher cell death.
Growth curve and TD of A549 human lung cancer cells
The growth curve of A549 cells is shown in Figure 1 . Cell proliferation was initially slow within the first 48 hours, but thereafter rose rapidly and peaked after 6 days, followed by a decline on the 7 th and 8 th days. The value of TD obtained was 20.
Inhibitory activity of CNCE
Results from MTT assay showed that CNCE exerted a concentration and time-dependent inhibitory effects on the growth of human lung cancer A549 cells ( Table 2 ). The inhibitory effect was highest at a concentration of 320 µg/mL. In addition, for each CNCE concentration, the inhibitory effect increased with time and became maximum at 96 h. Effect of CNCE on A549 cell apoptosis and cell cycle CNCE at a concentration of 40 μg/mL brought about aCNCEst of cell cycle at G0/G1 phase in 24 and 48 h, and blocked the transformation from G1 phase to S phase (Table 3) . With increase in G0 -G1 phase transition time, there was reduction in the number of cells in the S phase. The increases in percentage of cells in the G0/G1 phase, and decreases in cells in S phase, were concentration-dependent and timedependent (p < 0. 01). 
Effect of CNCE on key enzymes of apoptosis and protein expression levels of apoptosisrelated genes
Immunocytochemistry results showed that CNCE at 40 ug/mL brought about significant increases in the expressions of apoptosis-related proteins caspase-3, caspase-8 and caspase-9 in 24 h, when compared with control (p < 0.01, Table 4 ). Visible light microscopy showed Ki-67 protein staining in the nucleus; and BCL-2 and p21 ras protein in the cytoplasm. There were more positive cells in the control group, but at a concentration of 40 μg / mL, there were significant decreases in the number of positive cells (p < 0. 01). The level of protein expression was significantly higher in the CNCE group than in the control group (p < 0. 01, Table 5 ). 
DISCUSSION
The results obtained in this study show that CNCE has significant time-and concentrationdependent inhibitory effects on the proliferation of A549 cells. The extract also exerted strong apoptotic effects on the A549 cells, as seen from the morphological changes in the cells. The dynamics of tumor cell proliferation are due to loss of control of cell cycle, resulting in uncontrolled G1 / S and G2 / M transformations. The cells were mainly in the active DNA synthesis S phase, which led to abnormal cell proliferation [5] . Thus blockage of the G1/S phase and G2/M phase can effectively control the tumor cell cycle and inhibit tumor proliferation.
In this study, results from cell cycle analysis showed that CNCE reduced the number of A549 human lung cancer cells in G1, S and G2/M phases, leading to stagnation of the cell cycle and restraining of cell proliferation. Increased concentrations of aqueous fractions of CNCE brought about enhanced effects on cell cycle aCNCEst. This indicates that CNCE causes lung cancer cell cycle aCNCEst by regulation and inhibition of tumor cell mitosis.
Ki-67 antigen is a more positive marker of nuclear proliferation, and Ki-67 may be used as a biomarker for determining high risk individuals in pre-cancer population [7] [8] [9] . Results from Ki-67 antigen assay showed that CNCE significantly decreased the expression of Ki-67 in A549 cells. This implies that a large number of the A549 cancer cells were in the stationary phase of cell cycle. In effect, CNCE may contain active principles that regulate the gene which inhibits cancer cell mitosis, thereby inhibiting the growth of tumor cells.
P21 ras cancer gene is involved in transmission of intracellular information which regulates the cell cycle, and it is the "initiation factor" in the occuCNCEnce of tumors [10] [11] [12] [13] . The expression of p21ras antigen was also significantly decreased in the CNCE-treated A549 cells, in a time-and concentration-dependent manner, when compared with untreated controls. Again, this is an indication that most of the cancer cells were in the S phase of the cell proliferation cycle. This supports the presence of anti-proliferative and mitosis-inhibiting agents in CNCE.
Caspases are proteolytic enzymes which constitute key components of the apoptosis system. They are a family of cysteine proteases involved in regulation of apoptosis, which is considered to be a key to cancer cell death [14] [15] [16] [17] . In this study, CNCE treatment led to significantly lowered expression of Bcl-2, and significant increases in the expression of caspase-9. These results demonstrate that the anti-proliferative effects CNCE also involve the mitochondrial apoptotic pathway.
Caspase-3 is a pro-apoptosis caspase. Its expression in the CNCE-treated A549 human lung cancer cells was significantly higher than in the untreated control cells, indicating that CNCE promotes apoptosis in these cells. Thus, CNCE induced apoptosis by inhibiting the signal transduction pathway enzymes to achieve elevated expressions of the pro-apoptosis caspases 3, 8 and 9; as well as the apoptosisrelated gene Bcl-2.
CONCLUSION
The findings of this study reveal that CNCE has significant effect on the inhibition of proliferation and induction of apoptosis in human lung cancer A549 cells. These findings suggest that the plant material might be a potent source of drugs for the treatment of lung cancer patients.
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